These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 16980293

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
    Capone A, D'Arezzo S, Visca P, Petrosillo N, Gruppo Romano Acinetobacter baumannii.
    J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii.
    Hawser SP, Hackel M, Person MB, Higgins PG, Seifert H, Dowzicky M.
    Int J Antimicrob Agents; 2010 Sep; 36(3):289-90. PubMed ID: 20558046
    [No Abstract] [Full Text] [Related]

  • 9. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ, Goff DA, Stevenson KB, Mangino JE.
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial.
    Hoban DJ, Bouchillon SK, Dowzicky MJ.
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):423-8. PubMed ID: 17403448
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ.
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
    Morfin-Otero R, Dowzicky MJ.
    Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reduced susceptibility of multidrug-resistant Acinetobacter baumannii to tigecycline in combination with 1-(1-naphthylmethyl)-piperazine is not a pH-dependent phenomenon.
    Wareham DW, Gordon NC, Casals JB, Bean DC.
    J Antimicrob Chemother; 2009 May; 63(5):1075-6. PubMed ID: 19279048
    [No Abstract] [Full Text] [Related]

  • 17. Isolation of uncommon respiratory and enteric Acinetobacter baumannii from hematologic patients and emergence of tigecycline-resistance.
    Savini V, Catavitello C, Pompetti F, Talia M, Costanzi L, Balbinot A, Febbo F, Di Zacomo S, Esattore F, D'Antonio D.
    J Infect; 2008 Dec; 57(6):497-500. PubMed ID: 19027170
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.
    Eser OK, Ergin A, Tunçkanat F, Hasçelik G.
    New Microbiol; 2008 Oct; 31(4):535-42. PubMed ID: 19123310
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.